Unsatisfied Reporting Quality of Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy in Cancer

Unsatisfied Reporting Quality of Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy in Cancer

BackgroundMore and more immune-oncology trials have been conducted for treating various cancers, yet it is unclear what the reporting quality of immune-oncology trials is,and characteristics associated with higher reporting quality.ObjectiveThis study aims to evaluate the reporting quality of immune...

Full description

Bibliographic Details
Main Authors:	Chen Chen, Yixin Zhou, Xuanye Zhang, Yuhong Wang, Li-na He, Zuan Lin, Tao Chen, Yongluo Jiang, Shaodong Hong, Li Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Immunology
Subjects:	reporting quality clinical trials immune checkpoint inhibitor immune therapy cancer evaluating
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.736943/full

Similar Items

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis
by: Yixin Zhou, et al.
Published: (2018-12-01)

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
by: Tao Jiang, et al.
Published: (2020-06-01)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis
by: Hanping Wang, et al.
Published: (2020-01-01)

A novel gene signature based on five immune checkpoint genes predicts the survival of glioma
by: Wei Zhang, et al.
Published: (2021-02-01)

Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity
by: Xiaoxiao Guo, et al.
Published: (2020-02-01)

Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
by: Jiaxin ZHOU, et al.
Published: (2019-10-01)

Management of immune checkpoint inhibitor‐related rheumatic adverse events
by: Jiaxin Zhou, et al.
Published: (2020-01-01)

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
by: Junling Zhuang, et al.
Published: (2020-03-01)

Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events
by: Junling ZHUANG, et al.
Published: (2019-10-01)

Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction
by: Lian Duan, et al.
Published: (2020-04-01)

Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor
by: Hanping WANG, et al.
Published: (2019-10-01)

Predictive biomarkers for tumor immune checkpoint blockade
by: Tong M, et al.
Published: (2018-10-01)

Management of immune checkpoint inhibitor‐related dermatologic adverse events
by: Xiaoyan Si, et al.
Published: (2020-02-01)

Management of Dermatologic Toxicities Related to Immune Checkpoint Inhibitors
by: Xiaoyan SI, et al.
Published: (2019-10-01)

The regulation of immune checkpoints by the hypoxic tumor microenvironment
by: Min Hu, et al.
Published: (2021-05-01)

New Immune Checkpoint: Advances in Immunotherapy for Malignant Tumors
by: YANG Changliang, et al.
Published: (2018-12-01)

Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy
by: Li-na He, et al.
Published: (2021-01-01)

Clinical Diagnosis and Treatment of Immune-related Adverse Events of Edocrine System Related to Immune Checkpoint Inhibitors
by: Lian DUAN, et al.
Published: (2019-10-01)

A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint
by: Xiaohan Zhou, et al.
Published: (2021-07-01)

Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile
by: Dafeng Xu, et al.
Published: (2020-06-01)

Age-Related Differences in Molecular Profiles for Immune Checkpoint Blockade Therapy
by: Qi-jie Zhang, et al.
Published: (2021-04-01)

Rheumatic Immune-related Adverse Events and Treatment of Immune Checkpoint Inhibitors
by: ZHANG Xue, et al.
Published: (2020-11-01)

Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition
by: Xuanye Zhang, et al.
Published: (2019-11-01)

Clinical Development of Immune Checkpoint Inhibitors in Patients with Small Cell Lung Cancer
by: Shuang ZHANG, et al.
Published: (2017-09-01)

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
by: Fei Liang, et al.
Published: (2020-08-01)

Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis
by: Xi-Yang Tang, et al.
Published: (2021-07-01)

The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
by: Yongchao Zhang, et al.
Published: (2021-01-01)

Research Progress of Histone Deacetylase Inhibitor Combined with  Immune Checkpoint Inhibitor in the Treatment of Tumor
by: Chen FANG, et al.
Published: (2021-03-01)

Clinical Diagnosis and Treatment Recommendation of Immune-related Adverse Renal Events Related to Immune Checkpoint Inhibitor
by: Wei QIU, et al.
Published: (2019-10-01)

Cytosolic Delivery of Thiolated Neoantigen Nano‐Vaccine Combined with Immune Checkpoint Blockade to Boost Anti‐Cancer T Cell Immunity
by: Da Zhang, et al.
Published: (2021-03-01)

Potential predictive value of SCN4A mutation status for immune checkpoint inhibitors in melanoma
by: Weiyin Lin, et al.
Published: (2020-11-01)

Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis
by: Ya-Qin Wang, et al.
Published: (2019-11-01)

Management of immune checkpoint inhibitor‐related adverse events: A review of case reports
by: Xiaoyan Si, et al.
Published: (2020-03-01)

Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
by: Shaoping Shen, et al.
Published: (2020-08-01)

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
by: Jinhua Liu, et al.
Published: (2021-09-01)

Clinical observation of immune checkpoint inhibitors in the treatment of advanced pancreatic cancer: a real-world study in Chinese cohort
by: Sun D, et al.
Published: (2018-09-01)

Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
by: María Gutiérrez-Larrañaga, et al.
Published: (2021-09-01)

The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
by: Patrizia Leone, et al.
Published: (2021-05-01)

Recommendation of Diagnosis and Management for the Infections Related to Immune Checkpoint Inhibitors
by: Minya LU, et al.
Published: (2019-10-01)

Recommendation for the diagnosis and management of immune checkpoint inhibitor related infections
by: Minya Lu, et al.
Published: (2020-03-01)

Cannot write session to /tmp/vufind_sessions/sess_kn8c34mdbo0fpasf6sfvrkg1tu